Apyx Medical Corp

The company is a surgical aesthetics company that develops innovative products for cosmetic and hospital surgical markets. Its key products include the Helium Plasma Platform Technology products, Renuvion and J-Plasma, and the AYON Body Contouring System. Renuvion and J-Plasma provide surgeons with controlled heat for tissue. AYON is an FDA-cleared, surgeon-designed body contouring system that integrates fat removal, closed-loop contouring, and Renuvion's tissue contraction and electrosurgical capabilities. The company also uses its expertise in unique waveforms through OEM agreements with other medical device manufacturers. On May 13, 2025, the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AYON. It completed a soft launch of AYON and commenced its commercial launch in September 2025. AYON is designed as an all-in-one system for comprehensive body contouring, integrating advanced modalities to perform multiple functions. These functions include infiltration, dual aspiration for simultaneous users, ultrasound-assisted liposuction, electrocoagulation for excess tissue removal, volume enhancement capabilities, and Renuvion treatment for loose and lax skin. On October 13, 2025, the company submitted a 510(k) premarket notification to the FDA for AYON's label expansion to include power liposuction.